Order Juvéderm® Volux w/ Lidocaine for Clinics

Juvéderm® Volux w/ Lidocaine is a crosslinked hyaluronic acid dermal filler for professional injection by trained healthcare practitioners. Licensed clinics can order Juvéderm Volux with Lidocaine in a 2 x 1 mL pre-filled syringe pack for lower-face contouring workflows, including chin projection and mandibular line definition. The formulation includes lidocaine to support procedural comfort during treatment-room use.

Med Wholesale Supplies serves licensed clinics, med spas, and healthcare professionals sourcing authentic brand-name medical products through vetted distributors and verified supply channels. This presentation is intended for professional use only, with clinic documentation, injector training, and local protocol review guiding purchase and administration.

Clinic Price, Pack Size, and Ordering Details

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account. Each box contains two 1 mL pre-filled syringes and four sterile 27G 1/2 inch needles, which supports bilateral lower-face planning, staged refinement, or controlled inventory allocation for scheduled aesthetic sessions.

The Juvéderm Volux with Lidocaine 2 x 1 mL format is useful for practices that standardize stock by treatment area and injector preference. When placing a purchase order, align the requested quantity with your appointment schedule, expected retouch policy, and internal stock rotation rules. Labels include lot and expiry information to support intake records and traceability.

Quick tip: Keep lot, expiry, injector, and treatment-area documentation aligned with your clinic’s existing injectable-product records.

What This HA Filler Is Designed to Do

Juvéderm Volux with Lidocaine is a dense, cohesive hyaluronic acid gel designed for structural support in aesthetic contouring. Hyaluronic acid is a water-binding substance used in many dermal fillers; crosslinking helps the gel maintain shape and resist rapid breakdown. In this product, the gel is formulated at 25 mg/mL hyaluronic acid with 3 mg/mL lidocaine in a phosphate-buffered system at pH 7.2.

In clinical aesthetic practice, trained injectors use this type of high-structure filler to refine the jawline, support chin projection, and improve lower-face definition within an individualized treatment plan. The product is supplied ready for injection and should be used only by qualified professionals familiar with facial anatomy, vascular risk, aspiration or cannula preferences, aseptic technique, and adverse-event response procedures.

The integrated anesthetic is included to reduce injection-site discomfort. Clinics may still use their usual patient preparation and pain-management protocol when appropriate, but lidocaine in the syringe can streamline setup and reduce the need for separate anesthetic steps in some workflows.

Professional Applications in Lower-Face Contouring

Juvéderm Volux filler with Lidocaine is commonly selected when definition, projection, and angle control matter more than superficial softening. Lower-face cases may involve chin support, mandibular border refinement, or a broader harmonization plan that also addresses the midface, lips, or skin quality. The 1 mL syringe format gives injectors measured control while supporting symmetrical planning across the jawline.

For broader clinical context on technique planning, anatomy awareness, and documentation, clinics can review jawline filler workflow considerations. Practices standardizing Allergan Aesthetics products may also find Juvéderm formulation and clinic workflow guidance useful when training staff or organizing treatment-room processes.

Volux is not simply a general-purpose soft filler. Its role is structural contouring, so injector selection should consider tissue thickness, skeletal support, facial proportions, prior filler history, and the amount of projection required. Patient counseling should cover expected swelling, bruising, realistic contour goals, follow-up timing, and signs that require urgent clinical contact.

Key Features for Clinic Inventory

• Crosslinked hyaluronic acid gel formulated for structural contouring tasks.
• 25 mg/mL hyaluronic acid concentration in a cohesive gel system.
• 3 mg/mL lidocaine hydrochloride to support procedural comfort.
• Two sterile 1 mL pre-filled syringes per box.
• Four sterile 27G 1/2 inch needles included for single-use injection setup.
• Phosphate buffer at physiologic pH to support formulation stability.
• Clinic-ready presentation with lot and expiry details for traceability.
• Reference SKU: 89433.

These packaging details help clinics plan stock by appointment type rather than opening excess units. The two-syringe box can support bilateral work or a planned staged approach when the treating practitioner chooses to separate initial contouring from refinement.

Composition and Mechanism

The active structural material is crosslinked hyaluronic acid gel. Hyaluronic acid attracts and holds water, while crosslinking changes the gel’s resistance, cohesion, and duration profile compared with non-crosslinked HA. In lower-face contouring, those handling characteristics can help an experienced injector build projection and maintain sharper definition.

The product is intended for single-patient professional use. Do not resterilize, reuse, or transfer remaining gel between patients. Follow the manufacturer’s instructions for use, your clinic’s aseptic protocol, and applicable professional standards for injectable implants.

Handling, Storage, and Treatment-Room Workflow

Store and handle the product according to the manufacturer’s packaging and instructions for use. Keep syringes in their original packaging until setup, protect sterile components from contamination, and inspect the box, syringe, needle packaging, lot number, and expiry date before use. Do not use the product if packaging integrity is compromised or if the product appearance conflicts with the manufacturer’s directions.

During intake, many clinics log the product name, quantity, lot, expiry, receiving date, and assigned storage location. During treatment, staff should document the syringe used, injection area, injector, needle or cannula choice, and patient response according to clinic policy. When required, we can coordinate temperature-controlled handling when required and tracked US delivery.

For practices that manage a wider injectable inventory, the dermal fillers category can help staff organize adjacent HA products, while the Juvéderm brand portfolio supports product-line standardization across facial regions.

Safety, Contraindications, and Monitoring

Dermal filler injections carry known procedural and product-related risks. Common short-term injection-site effects can include swelling, tenderness, redness, itching, bruising, firmness, discoloration, and localized discomfort. These effects are often temporary, but clinics should provide patients with clear aftercare instructions and a defined pathway for reporting concerns.

Serious complications can occur if filler is injected into or compresses a blood vessel. Potential vascular events may include skin blanching, severe pain, tissue injury, scarring, or visual symptoms. Injectors should understand facial vascular anatomy, use appropriate technique, monitor tissue response during treatment, and have an emergency protocol for suspected vascular compromise.

Screen patients according to the product labeling and clinic protocol before treatment. Important checks may include history of severe allergy, hypersensitivity to lidocaine or amide-type local anesthetics, active infection or inflammation near the injection site, bleeding risk, recent procedures, immune status, prior filler placement, and medications or supplements that may increase bruising. Individual suitability remains a clinician-led decision.

Clinics can support staff education with Juvéderm side-effect monitoring considerations. Any unexpected or serious adverse event should be documented and reported through the clinic’s usual pharmacovigilance or device-reporting channels.

Expected Duration and Counseling Points

Duration varies by product characteristics, treatment area, injection depth, patient metabolism, expression patterns, and follow-up strategy. For chin and jawline contouring, counseling should avoid fixed promises and instead explain that results are assessed after initial swelling settles and may be maintained with review visits when clinically appropriate.

Clinics answering patient questions about chin support can use chin filler duration counseling to frame realistic expectations. The discussion should include asymmetry, swelling, bruising, tenderness, temporary firmness, and the possibility that staged treatment may be safer or more aesthetically controlled than attempting a full correction in one visit.

Because lower-face fillers influence facial proportions, photographs, consent notes, baseline anatomy assessment, and follow-up planning are especially important. A structured workflow helps the injector separate normal early swelling from findings that require clinical review.

How Volux Fits Within the Juvéderm Range

Juvéderm is a family of hyaluronic acid dermal fillers with different gel characteristics for different aesthetic goals. Volux is generally used when lower-face structural definition is the priority. Other products in the range may be better suited to midface volume, lip contour, perioral refinement, or skin-quality support depending on the clinical plan.

For midface volume and lifting plans, clinics may consider Juvéderm Voluma with Lidocaine. When a softer facial contouring profile is needed, Juvéderm Volift with Lidocaine may fit different tissue and movement goals. For lip or fine-area planning, Juvéderm Volbella with Lidocaine may be reviewed as part of a broader treatment menu.

No filler is inherently better for every case. Product choice should reflect the target tissue plane, desired projection, rheology, injector technique, patient anatomy, and the safety profile described in the relevant instructions for use.

Ordering and Logistics for Licensed Practices

Include any intake notes that your facility uses for receiving, documentation, or inventory assignment.

US distribution supports predictable replenishment for practices that schedule injectable sessions in advance. To avoid last-minute substitution decisions, align ordering with your calendar, expected consultation conversions, and retouch policy. If this exact item is not suitable for a planned protocol, review alternatives with your clinical lead before appointments are booked.

Why it matters: Product selection, lot documentation, and trained administration all affect safe lower-face filler workflows.

Authoritative and Professional References

For clinical use, rely on the manufacturer’s current instructions for use, package materials, and your clinic’s professional training standards. General dermal filler safety information is also available from the American Society for Dermatologic Surgery dermal filler information. Use external references to support safety education, not as a replacement for product-specific labeling or hands-on injector training.

This content is for informational purposes only and is not a substitute for professional medical advice.